Food

EzCater Gobbles $35M From Iconiq Capital, Insight Venture Partners

One year ago   |   By Xconomy

Boston online food-ordering company ezCater has hauled in another big venture capital round. Today the company announced a $35 million investment led by new backer Iconiq Capital; Insight Venture Partners, a previous ezCater investor, also chipped in. EzCater says it has raised $70 million in total venture capital, including a $28 million round announced in October 2015 . EzCater got started in 2007, before there was a glut of companies offering food delivery at the push of a smartphone button. But while most online food-ordering startups have targeted consumers, ezCater opted to serve...
Read more ...

 


Search by Tags

   Food      Boston      Boston blog main      Boston top stories      National blog main      Apps      David Meiselman      EzCater      Food delivery      Food ordering      Iconiq Capital      Insight Venture Partners      Mobile      On demand      Software      Startups      Stefania Mallett      Tech      VC  


14th International Conference on Generic Drugs and Biosimilars

Conference series takes pleasure in inviting the scientific community across the globe to attend the 14th International Conference on Generic Drugs & Biosimilars during... Read more ...

14th International Conference on Generic Drugs and Biosimilars

14th International Conference on Generic Drugs and Biosimilars November 15-16, 2018 | Berlin, Germany Best Western Premier Airporthotel Fontane Berlin Theme: A new Era in... Read more ...

Annual DIA Meeting 2017

Annual DIA Meeting 2017

From June 18-22, CORE Clinical will be attending the DIA conference in Chicago. From the people who pioneered the imaging CRO comes new thinking in image management, workflow... Read more ...

Invenra, Madison Firm Developing Therapeutic Antibodies, Adds $7.1M

Invenra, Madison Firm Developing Therapeutic Antibodies, Adds $7.1M

Invenra , a Madison, WI-based startup that develops therapeutic antibodies for pharmaceutical companies and other clients, has raised more than $7.1 million from investors... Read more ...

TP Therapeutics Names New CEO, Gets $80M More For Cancer Drug Push

TP Therapeutics Names New CEO, Gets $80M More For Cancer Drug Push

Five-year-old biotech TP Therapeutics has raised an $80 million mezzanine financing round and promoted its chief medical officer, Athena Countouriotis, to CEO. The San... Read more ...

IAmScience Amanda Blythe

IAmScience Amanda Blythe

By Erica Overfelt | Bond LSC You could credit a high school career fair to Amanda Blythe's early success or simply luck. Either way, Blythe was younger than most when her... Read more ...

Boston Tech Watch: IBM, DataXu, Accion, Yottaa, CoachUp & More

Boston Tech Watch: IBM, DataXu, Accion, Yottaa, CoachUp & More

Rumors of a Boston adtech sale, a top-level departure at IBM's Watson Health business, more cash to boost A.I. startups, and Boeing backing a space propulsion company dominate... Read more ...

LogicBio Prices IPO Below Range, Raising $70M to Test Gene Therapy

LogicBio Prices IPO Below Range, Raising $70M to Test Gene Therapy

LogicBio Therapeutics has joined the list of biotechs to go public this year but it had to cut the price of its IPO and sell more shares to pull it off. The Cambridge, MA... Read more ...

Bio Roundup: Prices on TV, Novartis Hearts Radio, Warp Drive's End

Bio Roundup: Prices on TV, Novartis Hearts Radio, Warp Drive's End

Two new battlegrounds emerged this week in the nation's ongoing drug pricing debate. The first involved television: The federal government hopes that blaring prices in TV ads... Read more ...

Novel immune syndrome described

Researchers have discovered a new human immunodeficiency syndrome in two patients on separate continents. The study reveals that a mutation in a gene called IKBKB disrupts the... Read more ...

TNER: a novel background error suppression method for mutation detection in...

Ultra-deep next-generation sequencing of circulating tumor DNA holds great promise as a tool for the early detection of cancer and for monitoring disease progression and... Read more ...

Research Specialist

ABOUT TEAM: The Huang Lab at UCSF, is currently developing a team of forwarding and innovative clinical research scientists who share the vision of curing cancer using the... Read more ...

Preclinical Toxicologist - Sorrento Therapeutics - San Diego, CA

Sorrento Therapeutics is seeking an experienced Preclinical Toxicologist to provide scientific expertise and leadership across the portfolio by...From Sorrento Therapeutics... Read more ...